article · 2019
Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial
Morihisa Hirota, Tooru Shimosegawa, Katsuya Kitamura, Kazunori Takeda, Yoshifumi Takeyama, Toshihiko Mayumi, Tetsuhide Ito, Mamoru Takenaka
43 citationsJournal of GastroenterologyDOI: https://doi.org/10.1007/s00535-019-01644-zOpen accessPDF reported by metadataFull text reported by metadata